301 related articles for article (PubMed ID: 27098119)
1. Anti-gastric cancer activity in three-dimensional tumor spheroids of bufadienolides.
Wang J; Zhang X; Li X; Zhang Y; Hou T; Wei L; Qu L; Shi L; Liu Y; Zou L; Liang X
Sci Rep; 2016 Apr; 6():24772. PubMed ID: 27098119
[TBL] [Abstract][Full Text] [Related]
2. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom.
Liu JS; Deng LJ; Tian HY; Ruan ZX; Cao HH; Ye WC; Zhang DM; Yu ZL
Fitoterapia; 2019 Apr; 134():362-371. PubMed ID: 30872126
[TBL] [Abstract][Full Text] [Related]
4. Structure-cytotoxic activity relationship for the toad poison bufadienolides.
Kamano Y; Kotake A; Hashima H; Inoue M; Morita H; Takeya K; Itokawa H; Nandachi N; Segawa T; Yukita A; Saitou K; Katsuyama M; Pettit GR
Bioorg Med Chem; 1998 Jul; 6(7):1103-15. PubMed ID: 9730247
[TBL] [Abstract][Full Text] [Related]
5. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers.
Li F; Weng Y; Wang L; He H; Yang J; Tang X
Int J Pharm; 2010 Jun; 393(1-2):203-11. PubMed ID: 20385221
[TBL] [Abstract][Full Text] [Related]
7. Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids.
Senkowski W; Jarvius M; Rubin J; Lengqvist J; Gustafsson MG; Nygren P; Kultima K; Larsson R; Fryknäs M
Cell Chem Biol; 2016 Nov; 23(11):1428-1438. PubMed ID: 27984028
[TBL] [Abstract][Full Text] [Related]
8. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates.
Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA
Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
Frankel A; Buckman R; Kerbel RS
Cancer Res; 1997 Jun; 57(12):2388-93. PubMed ID: 9192815
[TBL] [Abstract][Full Text] [Related]
10. Microbial transformation of three bufadienolides by Nocardia sp. and some insight for the cytotoxic structure-activity relationship (SAR).
Zhang J; Sun Y; Liu JH; Yu BY; Xu Q
Bioorg Med Chem Lett; 2007 Nov; 17(22):6062-5. PubMed ID: 17911017
[TBL] [Abstract][Full Text] [Related]
11. Isolation and identification of l/d-lactate-conjugated bufadienolides from toad eggs revealing lactate racemization in amphibians.
Zhou S; Zheng Q; Huang X; Wang Y; Luo S; Jiang R; Wang L; Ye W; Tian H
Org Biomol Chem; 2017 Jul; 15(26):5609-5615. PubMed ID: 28639665
[TBL] [Abstract][Full Text] [Related]
12. Impact of the spheroid model complexity on drug response.
Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
[TBL] [Abstract][Full Text] [Related]
13. Development of a magnetic 3D spheroid platform with potential application for high-throughput drug screening.
Guo WM; Loh XJ; Tan EY; Loo JS; Ho VH
Mol Pharm; 2014 Jul; 11(7):2182-9. PubMed ID: 24842574
[TBL] [Abstract][Full Text] [Related]
14. Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch'an Su.
Nogawa T; Kamano Y; Yamashita A; Pettit GR
J Nat Prod; 2001 Sep; 64(9):1148-52. PubMed ID: 11575946
[TBL] [Abstract][Full Text] [Related]
15. Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics.
Solomon MA; Lemera J; D'Souza GG
J Liposome Res; 2016 Sep; 26(3):246-60. PubMed ID: 26780923
[TBL] [Abstract][Full Text] [Related]
16. LA-ICP-MS imaging in multicellular tumor spheroids - a novel tool in the preclinical development of metal-based anticancer drugs.
Theiner S; Schreiber-Brynzak E; Jakupec MA; Galanski M; Koellensperger G; Keppler BK
Metallomics; 2016 Apr; 8(4):398-402. PubMed ID: 26806253
[TBL] [Abstract][Full Text] [Related]
17. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
18. Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids.
Herrmann R; Fayad W; Schwarz S; Berndtsson M; Linder S
J Biomol Screen; 2008 Jan; 13(1):1-8. PubMed ID: 18040052
[TBL] [Abstract][Full Text] [Related]
19. High-throughput screening in multicellular spheroids for target discovery in the tumor microenvironment.
Calpe B; Kovacs WJ
Expert Opin Drug Discov; 2020 Aug; 15(8):955-967. PubMed ID: 32364413
[TBL] [Abstract][Full Text] [Related]
20. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions.
Wenzel C; Riefke B; Gründemann S; Krebs A; Christian S; Prinz F; Osterland M; Golfier S; Räse S; Ansari N; Esner M; Bickle M; Pampaloni F; Mattheyer C; Stelzer EH; Parczyk K; Prechtl S; Steigemann P
Exp Cell Res; 2014 Apr; 323(1):131-143. PubMed ID: 24480576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
